Eunah Cho, MD
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Reducing Fasting Time in Children for Sedation
Role: lead
Prediction Model for TOF
Role: lead
Oxygen Reserve Index to Reduce Hyperoxia
Role: lead
Preoperative Oral Carbohydrate Loading in Gynecologic Surgery
Role: lead
Ultrasonographic Assessment of Stomach in Two Different Fasting Guidelines
Role: lead
Comparison of Dexmedetomidine and Midazolam for Prevention of Emergence Delirium in Children
Role: lead
Endotracheal Tube Shapes for Intubation With Videolaryngoscope
Role: lead
Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)
Role: lead
All 8 trials loaded